‘People were really ready for it,’ says Dr. Ashish Atreja
NEW YORK – Mount Sinai Health has launched RxUniverse, a platform that enables physicians to digitally prescribe mobile health apps to patients.
“Apps have typically been recommended to patients verbally, but with the myriad of mobile health apps on the market, many with no proven evidence, it is a challenge for providers and patients,” said Dr. Ashish Atreja, chief technology innovation and engagement officer and director of the Sinai AppLab at the Icahn School of Medicine at Mount Sinai. “RxUniverse eliminates these uncertainties and barriers to digital medicine.”
RxUniverse features a curated list of apps that have been evaluated for efficacy based on published evidence and incorporated into a digital prescription delivery system. The platform was launched in a pilot phase in August throughout five clinical areas of Mount Sinai.
Since then, participating physicians have prescribed more than 2,000 apps, exceeding 20 times the pilot goal.
“There was such a big hunger to use these tools,” said Atreja. “We really didn’t have to do any prep work, people were really ready for it.”
As a result of the pilot’s success, the Sinai AppLab has partnered with Mount Sinai Innovation Partners to launch Responsive Health, a new startup company that will license RxUniverse for use by other health systems.
RxUniverse is part of a larger ecosystem called the Network of Digital Evidence (NODE Health), which provides a community forum and structure for health system technology experts, digital medicine tech companies, clinicians and patients to come together around digital medicine and the state of scientific evidence surrounding its design, efficacy and implementation, the hospital said.
RxUniverse can also be used for specifically tailored educational content, patient satisfaction surveys and other tools that can be digitally prescribed in individual patients or entire populations.
“Our goal now is to take this and see if we can really change the landscape of health care,” Atreja said.